$HYFT Cashflow Statement | Understand Stock

$HYFT

$1.16 +$0.01 (0.87%) Close

Financial Statements

In millions of CAD, except per-share amounts

	FY2026 12 months to Apr 30, 2026	FY2025 12 months to Apr 30, 2025	FY2024 12 months to Apr 30, 2024	FY2023 12 months to Apr 30, 2023	FY2022 12 months to Apr 30, 2022
Operating activities:
Net loss for the year including discontinued operations
Adjustments not affecting cash:
Accretion
Amortization and depreciation
Asset impairment
Deferred income taxes
Foreign exchange
Gain on investment
Loss on disposal of subsidiary
Share-based expense
Items not affecting cash
Amounts receivable
Inventory
Unbilled revenue
Prepaid expenses
Accounts payable and accrued liabilities
Sales and income taxes payable and receivable
Deferred revenue
Net cash used in operating activities
Investing activities:
Purchase of equipment
Deposit on equipment
Purchase of BioStrand
Purchase of customer list
Sale of QVQ Holdings BV shares
Security depost on leases
Deferred acquisition payments
Proceeds on disposal of subsidiary
Net cash provided by (used in) investing activities

Financing activities:
Proceeds on share issuance, net of transaction costs
Share issue cost pursuant to the acquisition of BioStrand
Proceeds from debenture
Repayment of principal on leases
Net cash provided by financing activities
Increase (decrease) in cash during the year
Foreign exchange
Cash - beginning of the year
Cash - end of the year
Cash is comprised of:
Cash
Restricted cash
Cash paid for interest
Cash paid for income tax
Cash from discontinued operations:
Net cash used in operating activities
Net cash used in investing activities
Net cash used in financing activities

Comments